Clinical Trial Update: Pilot Study of Thalidomide to Treat Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating thalidomide for treatment of Sjogren's Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome
• Xerostomia

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Sjogren's Syndrome, Xerostomia | Phase 2 | Status: COMPLETED